FDA Drug Application (040029) for KIONEX by PADDOCK LLC

Back to FDA Applications sponsored by PADDOCK LLC

Application Number040029
Product Number001
FormPOWDER;ORAL, RECTAL
Dosage454GM/BOT
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AA Products in conventional dosage forms not presenting bioequivalence problems
Reference Drug
Drug NameKIONEX
Active IngredientSODIUM POLYSTYRENE SULFONATE

Active IngredientCount
List of drugs with Active Ingredient SODIUM POLYSTYRENE SULFONATE5


Back to FDA Applications sponsored by PADDOCK LLC